Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Vuzix Reports 4Q and Full Year 2023 Results
-
4Front Ventures Reports Fourth Quarter and Full Year 2023 Financial Results
-
Digital Brands Group Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
EPR Properties Declares Monthly Dividend for Common Shareholders
-
New Fortress Energy Schedules First Quarter 2024 Earnings Release and Conference Call
-
Two Harbors Investment Corp. Announces Earnings Release and Conference Call for First Quarter 2024 Financial Results
-
Universal Display Corporation Announces First Quarter 2024 Conference Call
-
SITE Centers’ First Quarter 2024 Earnings Conference Call to be Held on Tuesday, April 30, 2024, at 8:00 a.m. Eastern Time
-
TechnipFMC Awarded Large Subsea Contract for ExxonMobil Guyana’s Whiptail Project
-
CitiGroup Announces Full Redemption of Series D Preferred Stock
-
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
-
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
-
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
-
Beneficient to Participate in the Planet MicroCap Showcase on May 1-2, 2024
-
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
-
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
-
Atomera to Announce First Quarter 2024 Financial Results and Host Webinar on Thursday, April 25, 2024
-
Terex Names R. Mark Cox SVP Corporate Development
-
Silver Star Properties Provides Corporate Update
-
Envista Announces CEO Appointment
-
First Trust Energy Infrastructure Fund Issues Notice Regarding April 2024 Distribution
-
Tidewater Utilities Announces Strategy for Compliance With New EPA PFAS Regulation
-
Inseego Corp. to Report First Quarter 2024 Financial Results on May 9, 2024
-
Owens Corning Commences Tender Offer and Masonite Commences Consent Solicitation
-
AV Enters Teaming Agreement with Parry Labs to Develop Modular Next-Generation Long Range Reconnaissance UAS
-
Dragonfly Energy Reports Fourth Quarter 2023 and Full Year Financial Results
-
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
-
Bile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort
-
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND ANNOUNCE PROPOSED MERGER
-
Caliber Reports Fourth Quarter and Full Year 2023 Results
-
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
-
Canadian Investment Regulatory Organization Trading Halt - RS.PR.A
-
KBRA Assigns Preliminary Ratings to SDR 2024-DSNY
-
Waraba Gold Limited Announces Private Placement to Fund Exploration Activities
-
Emmaus Life Sciences Reports Delayed Filing of Annual Report
-
Virgin Galactic Reports Inducement Award Under NYSE Listing Rule 303A.08
-
CNB Financial Corporation Reports First Quarter 2024 Results
-
Skillsoft Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
-
Quisitive Sets Fourth Quarter and Full Year 2023 Earnings Call for Monday, April 29, 2024 at 4:30 p.m. ET
-
Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 16, 2024
-
Mitek Reports Fiscal 2024 First Quarter Financial Results and Provides Preliminary Second Quarter Revenue Results
-
Teradata Announces 2024 First Quarter Earnings Release Date
-
Grid Dynamics to Announce First Quarter 2024 Financial Results on May 2nd
-
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
-
Stonegate Updates Coverage on Hooker Furniture Corporation (NASDAQ: HOFT) Q4 2023
-
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
-
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
-
Magnachip to Announce First Quarter 2024 Financial Results on May 2, 2024
-
Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)
-
PRA Group to Announce First Quarter 2024 Results on May 6

